Brightspring Health Services Inc (OQ:BTSG)
Business Focus: Home Healthcare Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 805 N Whittington Pkwy LOUISVILLE KY 40222-5186 |
| Tel: | N/A |
| Website: | https://www.brightspringhealth.com |
| IR: | See website |
| Key People | ||
| Jon B. Rousseau Chairman of the Board, President, Chief Executive Officer | James F. Mattingly Chief Financial Officer, Executive Vice President | Robert A. Barnes President - Community Living |
| Mike Mcmaude President - Home Health and Hospice Services | Jennifer Yowler President of PharMerica | Lisa Nalley Senior Vice President - Human Resources, Chief of Staff | Steven S. Reed Corporate Secretary, Chief Legal Officer |
| Business Overview |
| BrightSpring Health Services, Inc. provides a home and community-based healthcare services platform. The Company is focused on delivering complementary pharmacy and provider services to complex patients. It delivers services through two reportable segments: Pharmacy Solutions and Provider Services. It provides pharmacy services when and where demanded and as required by customers and patients in their homes and communities, often in coordination with its provider services. It delivers a variety of impactful and valuable provider services to high-need, chronic, and complex patients in home and community settings. Its platform offers complimentary pharmacy and provider services that more completely address the multiple needs of complex senior and specialty patients across their various settings and over time. Its presence spans all 50 states, it serves over 400,000 patients daily through its approximately 10,000 clinical providers and pharmacists. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Brightspring Health Services Inc revenues increased 14% to $8.83B. Net loss increased from $53.9M to $154.6M. Revenues reflect Pharmacy Solutions segment increase of 24% to $6.52B, Provider Services segment increase of 6% to $2.3B. Higher net loss reflects Selling, general and administrative expe increase of 14% to $1.29B (expense), Interest expense. |
| Employees: | 35,000 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $5,338M as of Dec 31, 2023 |
| Annual revenue (TTM): | $8,826M as of Dec 31, 2023 |
| EBITDA (TTM): | $519.88M as of Dec 31, 2023 |
| Net annual income (TTM): | -$154.60M as of Dec 31, 2023 |
| Free cash flow (TTM): | $137.26M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $3,385M as of Dec 31, 2023 |
| Shares outstanding: | 289,177,229 as of May 1, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.